Chong Kun Dang said its Indonesian joint venture CKD OTTO signed an export agreement worth $32 million with Saidal, the largest state-run pharmaceutical company in Algeria.Under the accord, CKD OTTO will ship anticancer injections produced at its Indonesian plant to Algeria for the next five years u
Celltrion’s Covid-19 antibody therapy Regkirona (ingredient: regdanvimab) received official authorization from the European Commission (EC) on Friday.The formal approval came just a day after the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended
Roche Diagnostics Korea's CustomBiotech team hosted an online meeting for researchers and companies developing mRNA technology on Thursday.More than 200 experts in charge of research and development (R&D) and production of mRNA technology shared their understanding of mRNA-based technology and futur
An Institute of Basic Sciences (IBS) research team has identified the principle that cancer suppressor protein ATAD5 regulates the termination of repairs on deoxyribonucleic acid (DNA) synthesis damaged by reactive oxygen.Researchers revealed that ATAD5 protein regulates DNA synthesis and finishes r
SK Biopharm said it launched a biotech company Ignis Therapeutics (Ignis), with 6 Dimensions Capital (6D), a healthcare investment firm based in Shanghai, to build a new drug development and commercialization platform in China.The establishment of Ignis in China led SK Biopharm to enter the top-4 gl
A real-world study has confirmed the safety and efficacy of Novartis’ gene therapy Zolgensma (ingredient: onasemnogene abeparvovec) in treating pediatric patients with spinal muscular atrophy (SMA) weighing up to 15 kilograms.The study demonstrated the safety and efficacy of Zolgensma in pediatric S
Hanmi Pharmaceutical said Thursday that its foreign partners are facilitating the global commercialization of the company’s anticancer drug candidates, such as HM43239, belvarafenib, and poziotinib.Aptose Bioscience, Roche and its subsidiary Genentech, and Spectrum Pharmaceuticals are speeding up th
A joint research team has recently found no sex-related impact on long-term risk of major adverse cardiac or cerebrovascular events (MACCE) after receiving a coronary intervention or bypass grafting.The team’s 10-year follow-up of the PRECOMBAT trial demonstrated similar rates of major adverse cardi
The government said Wednesday that the nation recorded the largest number of severe Covid-19 cases after the shift to the “living-with-Covid" regime earlier the month.Health officials confirmed 460 patients with severe conditions on Wednesday, breaking the previous record of 434 on Aug. 25.The offic
Pharos iBio said its PHI-501, a next-generation anticancer drug for acute myeloid leukemia (AML), has won orphan drug designation from the U.S. Food and Drug Administration (FDA).It was the U.S. regulator’s second orphan drug designation of the Korean company’s product. FDA granted similar status to
GemVax & KAEL said its study results of GV1001 showing an inhibitory effect on prostate cancer cell metastasis was published in the international journal, Cell & Bioscience.The company research team found the possibility that its Alzheimer’s drug candidate GV1001 could be a GnRHR ligand that inhibit
The Ministry of Food and Drug Safety (MFDS) will hold an annual Pharmaceutical Inspection Co-operation Scheme (PIC/S) seminar online from Tuesday to Thursday.It is the largest annual event in the good manufacturing practice (GMP) area. According to the ministry, experts from major regulatory agencie
A Pfizer executive said the company is aware of the alleged data fraud suspicion in its clinical trials of the Covid-19 vaccine Cominarty and conducts an internal review.Pfizer Vaccine Vice President Ralf Rene Reinert said at an online meeting that the company confirmed the article published by the
The Korea Drug Development Foundation (KDDF) has recently added a slew of candidates for next-generation drugs to the national drug development project to strengthen the competitiveness of the biopharmaceutical industry and secure medical sovereignty.The selected pharmaceutical companies, including
HLB's anticancer drug candidate rivoceranib has won an orphan drug designation from the U.S. Food and Drug Administration for treating liver cancer.The company is conducting global phase 3 clinical trials of rivoceranib and cancer immunotherapy camrelizumab as first-line treatment for liver cancer.H
Merck Biopharma Korea and Pfizer Korea said their joint immunotherapy Bavencio (ingredient: avelumab) received approval for treating urothelial carcinoma.Bavencio, the first and only FDA-approved anti-PD-L1 immunotherapy, was first authorized to treat Merkel cell carcinoma in 2019 and received regul
SK Bioscience said Friday that its Covid-19 vaccine candidate has shown excellent outcomes in phase 1 and 2 clinical trials.As the company has analyzed the results of previous clinical trials of its Covid-19 vaccine candidate and the ongoing phase 3 clinical trials, it expects to present the first h
Medytox said that the Korea Drug Development Fund (KDDF) has selected Bruton's tyrosine kinase (BTK) inhibitor-based anticancer drug MT106 development project as a new national drug development project.The national new drug development project is a cross-ministerial R&D project established to secure
Korea recorded 24 deaths caused by the Covid-19, the highest since Jan. 12 when 25 people died of the disease, after implementing relaxed infection control for the fourth day.The figure also marks the largest deaths counted after the fourth Covid-19 wave began to spread throughout the nation in earl
The Korean government should improve the regulatory regime to introduce decentralized clinical trials (DCT) to cope with the new environment for developing drugs, as seen during the Covid-19 pandemic, foreign experts said on Wednesday.Medidata, a company leading the digital transformation of life sc